Pfizer Taps Into 'Doggybone DNA' For mRNA Vaccines, Gene Therapy Production

Targets Manufacturing Bottleneck

 
• By Andrew McConaghie
  
Pfizer
The deal allows Pfizer to manufacture 'doggybone DNA' in its own facilities, but further details have not been disclosed. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip